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Abstract. 
 
We report the identification and initial char-
acterization of paralemmin, a putative new morphoreg-
ulatory protein associated with the plasma membrane. 
Paralemmin is highly expressed in the brain but also 
less abundantly in many other tissues and cell types. 
cDNAs from chicken, human, and mouse predict acidic 
proteins of 42 kD that display a pattern of sequence 
cassettes with high inter-species conservation separated 
by poorly conserved linker sequences. Prenylation and 
palmitoylation of a COOH-terminal cluster of three 
cysteine residues confers hydrophobicity and mem-
brane association to paralemmin. Paralemmin is also 
phosphorylated, and its mRNA is differentially spliced 
in a tissue-specific and developmentally regulated man-
ner. Differential splicing, lipidation, and phosphoryla-
tion contribute to electrophoretic heterogeneity that 
results in an array of multiple bands on Western blots, 
most notably in brain. Paralemmin is associated with 
the cytoplasmic face of the plasma membranes of 
postsynaptic specializations, axonal and dendritic pro-
cesses and perikarya, and also appears to be associated 
with an intracellular vesicle pool. It does not line the 
neuronal plasmalemma continuously but in clusters and 
patches. Its molecular and morphological properties 
are reminiscent of GAP-43, CAP-23, and MARCKS, 
proteins implicated in plasma membrane dynamics. 
Overexpression in several cell lines shows that para-
lemmin concentrates at sites of plasma membrane ac-
tivity such as filopodia and microspikes, and induces 
cell expansion and process formation. The lipidation 
motif is essential for this morphogenic activity. We pro-
pose a function for paralemmin in the control of cell 
shape, e.g., through an involvement in membrane flow 
or in membraneÐcytoskeleton interaction.
Key words: farnesylation ¥ lipidation ¥ cortical cy-
toskeleton ¥ membrane traffic ¥ synapse
 
N
 
eurons
 
 possess an elaborate plasma membrane
architecture. The enormous arborization of these
cells not only implies a very high ratio of cell sur-
face to volume in a highly defined morphology, but this
surface is alsoÑparticularly at pre- and postsynaptic con-
tactsÑsubdivided into a complex mosaic of subdomains
with differential compositions of membrane proteins.
Moreover, synapses are hotspots of fast and strictly regu-
lated membrane dynamics. To construct, maintain, and re-
shape the complex plasma membrane architecture of neu-
rons, an interplay between the plasma membrane, exo/
endocytotic vesicles, and the cortical cytoskeleton must
permit or mediate membrane flow at dynamic sites but
stabilize the static regions. Demands on the control of
plasma membrane shape and composition are particularly
challenging at synapses, where rapid membrane flows oc-
cur within the constraints of a subtle micromorphology.
To identify new protein components of synapses, we
have previously raised antisera against synaptic plasma
membranes obtained by subcellular fractionation and
screened brain cDNA expression libraries for clones
whose expression products reacted immunopositive with
these sera. Among the proteins newly identified in this im-
munoscreen were: amphiphysin (Lichte et al., 1992), for
which an involvement in neurotransmitter vesicle re-endo-
cytosis has recently emerged (Shupliakov et al., 1997), and
that has also been identified as an autoantigen in paraneo-
plastic neurological autoimmune diseases (De Camilli et
al., 1993; Dropcho, 1996); myosin V, an unconventional
myosin (Sanders et al., 1992) that is affected by genetic de-
fects of exocytosis in yeast, mice, and humans (Johnston
et al., 1991; Mercer et al., 1991; Pastural et al., 1997), and
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functions as a motor protein in intracellular membrane
vesicle transport (e.g., in the extension of filopodia [Wang
et al., 1996] and at synapses [Prekeris and Terrian, 1997]);
and a homologue of 
 
m
 
-adaptins that presumably is a sub-
unit of a new type of vesicle coat involved in intracellular
membrane traffic (Wang and Kilimann, 1997). About 50%
of the clones picked up in this immunoscreen encoded
known proteins: GAP-43; MARCKS; N-CAM; the prion
protein as established proteins associated with neuronal
plasma membranes; CAP-23, a cortical cytoskeleton-asso-
ciated protein related to GAP-43; the molecular chap-
erones hsp70 and cyclophilin; the cytoskeletal proteins
MAP-1B, MAP-2, and ankyrin-B; and calmodulin. The only
obviously unspecific protein was a ferredoxin of presum-
ably mitochondrial origin. Notably, a significant fraction
of the novel and known proteins found in our immuno-
screen are implicated in membrane traffic or membraneÐ
cytoskeleton interaction.
In the present article, we describe the identification of
another new protein associated with synaptic plasma mem-
branes, paralemmin, and its initial molecular, morphol-
ogical and functional characterization. Paralemmin is a
hydrophilic protein anchored to membranes through a
COOH-terminal CaaX lipidation motif. It is highly ex-
pressed in neurons; it is found at the plasma membranes of
postsynaptic specializations, axonal and dendritic pro-
cesses, and perikarya. Paralemmin is also detectable at
lower levels in many other tissues and cell types. Several of
its molecular and morphological properties are reminis-
cent of GAP-43 and MARCKS, proteins implicated in
plasma membrane dynamics. Overexpression of paralem-
min in several cell lines induces cell expansion and process
formation, and we therefore propose a function for para-
lemmin, e.g., as a SNAP receptor (SNARE)
 
1
 
 or as a mem-
brane anchor for the cortical cytoskeleton, in the control
of cell shape.
 
Materials and Methods
 
cDNA Cloning, Sequencing, and RNA Analysis
 
Rabbit antisera against synaptic plasma membrane preparations from
chicken brain (age, 7Ð10 d) were raised and used for immunoscreening of
chicken brain cDNA expression libraries in 
 
l
 
gt11 as described (Lichte
et al., 1992). Conventional procedures were used for hybridization re-
screening of chicken, human (human fetal brain; Stratagene, La Jolla, CA),
and mouse brain (Hoesche et al., 1993) cDNA libraries and for DNA se-
quencing. Purification of RNA from various chicken and mouse tissues
and cell lines, oligo (dT) cellulose chromatography, Northern blotting,
and blot hybridization at high stringency were also performed according
to standard procedures (Hoesche et al., 1993, 1995). Human multiple tis-
sue Northern blots were purchased from CLONTECH Laboratories, Inc.
(Palo Alto, CA) and hybridized at high stringency according to the manu-
facturerÕs instructions. For reverse-transcribed polymerase chain reaction
(RT-PCR), total RNA or poly(A)
 
1
 
 RNA from mouse, human, or chicken
tissues were reverse transcribed and amplified, and the PCR products se-
quenced as described (Wllrich et al., 1993; Burwinkel et al., 1996).
Mouse cell lines NS20Y, N1E115, NH15CH2, 108CC15, and L929 were
cultivated in DME supplemented with 10% FCS at 8% CO
 
2
 
. To induce
morphological differentiation of neuroblastoma cells, the serum concen-
tration was reduced to 0.5% or 0.25%, and culture continued for 7 d. To
stimulate protein kinaseÐmediated signal pathways, 10 
 
m
 
M forskolin/0.5
 
m
 
M IBMX (3-isobutyl-1-methylxanthine), 0.6 
 
m
 
M of the calcium iono-
phore A23187, or a concentration series of 0.1 nM to 1 
 
m
 
M of the phorbol
ester 12-O-tetradecanoylphorbol-13-acetate (TPA), respectively, were
added and culture continued for 24 h. Northern blot analysis demon-
strated slight decreases in mRNA abundance under either condition, in
parallel to similar decreases of synapsin I mRNA abundance (Hoesche et al.,
1995) and therefore presumably unspecific in nature. The same Northern
blots used by Hoesche et al. (1995) were used for paralemmin mRNA hy-
bridization, allowing a direct comparison with synapsin I mRNA abun-
dance as control.
 
Monospecific Antisera and Immunoblotting
 
A rabbit antiserum against chicken paralemmin (amino acid 16 to COOH
terminus without exon 8) was raised against the 
 
b
 
-galactosidase fusion
protein of the initial cDNA clone ch10.12.1 as described (Lichte et al.,
1992). Two rabbit sera (Nos. 2 and 10) and a chicken serum (HB) were
raised against a partial mouse paralemmin sequence (amino acids 15Ð242
without exon 8) obtained by RT-PCR and fused to glutathione-S-trans-
ferase (GST) in the bacterial expression vector pGEX-3X (Pharmacia
Biotech, Inc., Piscataway, NJ). Two rabbit sera were raised against a
synthetic peptide (mouse paralemmin amino acids 13Ð27, ERLQAI-
AEKRRKQAE, plus a COOH-terminal cysteine) coupled to keyhole
limpet hemocyanin either with glutaraldehyde (serum No. 8) or with
3-maleimidoacetic acid 
 
N
 
-hydroxysuccinimide ester (MBS; No. 12). A
rabbit serum against recombinant chicken amphiphysin has been de-
scribed (Lichte et al., 1992). An mAb against the synaptic vesicle protein
SV2 (mouse IgG1, hybridoma SP2/0; Feany et al., 1992) was the gift of Dr.
K.M. Buckley (Harvard Medical School, Boston, MA).
For affinity purification of antiÐmouse paralemmin sera, the GST fu-
sion protein was proteolytically cleaved with coagulation factor X (Boeh-
ringer Mannheim Corp., Indianapolis, IN), the GST moiety removed by
chromatography over glutathione Sepharose, and the paralemmin moiety
coupled to tresyl Sepharose (both resins from Sigma Chemical Co., St.
Louis, MO). Sera (100 
 
m
 
l) were passed over the paralemmin column (1.4
ml), and bound antibodies eluted sequentially with 0.2 M glycine/HCl, pH
2.8, and 2 M MgCl
 
2
 
. Antibody-containing fractions were pooled, dialyzed
against PBS, and then stored at 
 
2
 
70
 
8
 
C. Mock affinity-purified preimmune
sera for controls were prepared in the same way. The specificity of affin-
ity-purified antibodies was confirmed by blocking experiments. Preincu-
bation with recombinant paralemmin completely abolished the reactivity
of the antibodies in immunoblot, immunofluorescence, and immunocy-
tochemistry experiments.
SDS-PAGE and immunoblotting onto nitrocellulose were performed
by standard methods, and immunoblots developed with alkaline phos-
phataseÐcoupled secondary antibodies (Dianova, Hamburg, Germany)
and the 5-bromo-4-chloro-3-indolyl-phosphate/
 
para
 
-nitrotetrazolium-
blue color reaction.
 
Subcellular Fractionation,
Deglycosylation, Triton X-114 Phase Partitioning,
and Hydroxylamine Hydrolysis
 
Tissue homogenates for immunoblotting were prepared by homogeniza-
tion in 0.32 M sucrose, 1 mM EDTA, 10 mM Tris, pH 7.4, 0.5 mM PMSF,
2 
 
m
 
g/ml pepstatin A, 2 
 
m
 
g/ml leupeptin, using a glass-Teflon homogenizer
or, for muscle and heart, a turning knife homogenizer. To prepare extracts
from cell lines NS20Y, L929, and PC12, cells were rinsed with PBS,
scraped from the dish in 20 mM Tris, pH 7.4, 2 mM EDTA, 0.5 mM
PMSF, 2 
 
m
 
g/ml pepstatin A, 2 
 
m
 
g/ml leupeptin, and sheared by 10 pas-
sages through a G27 syringe. These homogenates were spun for 3 min at
3,000 rpm (900 
 
g
 
) in a microcentrifuge, and the supernatant stored at
 
2
 
70
 
8
 
C.
Membrane and cytosolic fractions were prepared from cell line extracts
(900 
 
g
 
 supernatants) by a 120,000 
 
g
 
 centrifugation for 30 min at 4
 
8
 
C
(Chapman et al., 1992). After resuspending in homogenization buffer and
measuring the protein concentration, the fractions were diluted in SDS-
PAGE sample buffer and equal protein quantities run on a 9% polyacryl-
amide gel.
Subcellular fractionation leading to the purification of synaptic plasma
membranes was carried out by the method of Babitch et al. (1976), and
synaptic vesicles were purified according to Hell et al. (1988). Deglycosy-
lation reactions were performed on chicken synaptic plasma membrane
fractions 0.4/0.6 or 0.6/0.8 and on fetuin (Sigma Chemical Co.) as positive
 
1. 
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control, with 
 
N
 
-glycosidase F (
 
Flavobacterium meningosepticum
 
), O-gly-
cosidase (
 
Diplococcus pneumoniae
 
), and neuraminidase (
 
Vibrio chol-
erae
 
), all from Boehringer Mannheim Corp., under the conditions sug-
gested by the manufacturer.
Triton X-114 phase partitioning was carried out according to Bordier
(1981) and Pryde (1986). For hydroxylamine hydrolysis, synaptic plasma
membranes (50Ð130 
 
m
 
g protein) were incubated in 1 M hydroxylamine,
pH 7.5, 1% SDS, at 37
 
8
 
C for 1.5Ð4 h. A control incubation was carried out
in parallel in 1 M Tris, pH 7.5, 1% SDS. After incubation, the samples
were adjusted to final concentrations of 1% Triton X-114, 150 mM NaCl,
1 mM CaCl
 
2
 
, 10 mM Tris, pH 7.5, by addition of concentrated stock solu-
tions, and then subjected to phase partitioning. Before SDS-PAGE, deter-
gents were removed from the fractions by TCA precipitation, washing of
the protein precipitates with ice-cold acetone, and then resuspension in
sample buffer. The entire fractions were then run on a 9% polyacrylamide
gel and analyzed by Western blotting. Phase partitioning was either car-
ried out on virtually undiluted samples (end concentrations of 700 mM hy-
droxylamine or Tris, respectively) or after dilution to end concentrations
of 50 mM hydroxylamine or Tris, to test for possible effects of high hy-
droxylamine concentrations on phase partitioning. Under both conditions,
the hydroxylamine effect was the same (transition of half of paralemmin
into the aqueous phase), whereas paralemmin was nearly completely re-
tained in the detergent phase if Triton X-114 partitioning in 50 mM hy-
droxylamine was performed immediately after hydroxylamine addition.
 
Expression and Metabolic Labeling of Recombinant 
Chicken Paralemmin in COS-7 Cells
 
Chicken cDNA clone 10.12.1-dT1, extending from nucleotide (nt) 1 to
1,362, and encompassing the entire coding sequence without exon 8, was
excised from 
 
l
 
gt11 by EcoRI, blunted with Klenow enzyme, and then in-
serted into the SmaI site of eukaryotic expression vector pSVL (Pharma-
cia Biotech Corp.). Recombinant plasmid was transfected into COS-7
cells by the DEAEÐdextran/DMSO method. After the DMSO shock and
medium exchange, cells were cultivated in 6-well plates in medium A
(DME with 10% FCS, 250 
 
m
 
g/ml streptomycin, 250 units/ml penicillin) for
48 h before the addition of metabolic label. Labeling with [
 
3
 
H]mevalono-
lactone (DuPont-NEN, Boston, MA) according to Adamson et al. (1992)
was performed in medium C (medium A supplemented with 50 
 
m
 
M mevi-
nolin [lovastatin; gift of Dr. Alberts, Merck & Co., Inc., Rahway, NJ], an
inhibitor of HMG-CoA reductase). Cells were preincubated with medium
C for 3 h, and then labeled with 0.1 mCi [
 
3
 
H]mevalonolactone in 1 ml me-
dium C per well overnight. Labeling with [
 
3
 
H]palmitate (DuPont-NEN)
was carried out according to Karnik et al. (1993) at a reduced FCS concen-
tration to lower the background of unlabeled palmitate. For this purpose,
cells were preincubated for 5 h in medium A without FCS and 30 min in
medium A with 1% FCS, and then grown in 0.75 ml medium A with 1%
FCS plus 0.45 mCi [
 
3
 
H]palmitate per well. For labeling with [
 
35
 
S]methio-
nine and [
 
35
 
S]cysteine, cells were grown overnight in 0.75 ml of medium A
(without cold methionine and cysteine) plus 0.75 mCi Tran
 
35
 
S-Label (ICN
Biomedicals, Costa Mesa, CA) per well. Cells were harvested by washing
twice with 1 ml PBS and lysing with 0.5 ml 1% Triton X-100/0.5% deoxy-
cholate/100 mM NaCl/20 mM Tris (pH 7.4)/ 3 mM MgCl
 
2
 
/3 mM PMSF for
30 min on ice. The lysate was spun for 10 min at 12,000 rpm in a microliter
centrifuge to remove debris before storage at 
 
2
 
70
 
8
 
C, immunoprecipita-
tion, and then analysis by SDS-PAGE. Electrophoresis gels were soaked
in Amplify (Amersham Corp., Arlington Heights, IL) before drying and
exposure to X-ray film.
 
Metabolic Labeling of Paralemmin with 
 
32
 
P
 
NS20Y cells (10
 
6
 
 per dish) were seeded in 35-mm petri dishes and culti-
vated for 48 h. After replacement of the culture medium by 500 
 
m
 
l of la-
beling buffer (phosphate- and serum-free DME, supplemented with 10
 
m
 
M sodium phosphate, 0.5% BSA, and 200 
 
m
 
Ci [
 
32
 
P]phosphoric acid [ICN
Biomedicals] per dish), the cultivation was continued for another 4 h.
Cells were washed twice with 2 ml Locke buffer (140 mM NaCl, 2 mM
MgCl
 
2
 
, 2 mM CaCl
 
2
 
, 5.6 mM KCl, 5.6 mM glucose, 15 mM Hepes, pH 7.4),
lysed in 500 
 
m
 
l RIPA buffer (1% Triton X-100, 0.5% sodium deoxycho-
late, 150 mM NaCl, 3 mM MgCl
 
2
 
, 5 mM EGTA, 20 mM Tris-HCl, pH 7.4,
supplemented with 0.5 mM PMSF, 2 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml pepstatin
A, 1 mM sodium vanadate, 50 mM NaF, 10 mM 
 
para
 
-nitrophenylphos-
phate) on ice for 30 min, and the soluble extract obtained by centrifuga-
tion at 14,000 
 
g
 
 for 30 min at 4
 
8
 
C.
For immunoprecipitation, the extract was pre-cleared by incubation,
for 1 h each, with 1 
 
m
 
l crude preimmune serum and 25 
 
m
 
l pansorbin (Cal-
biochem-Novabiochem Corp., La Jolla, CA). After pelleting the pan-
sorbin, the supernatant was incubated with 1 
 
m
 
l of antiserum overnight
followed by 30 
 
m
 
l pansorbin for 2 h. All incubations were at 4
 
8
 
C on an
end-over-end mixer. The pansorbin pellet was washed three times in
RIPA buffer, resuspended in SDS sample buffer and subjected to SDS-
PAGE (9% polyacrylamide). After semidry blotting onto nitrocellulose
sheets, phosphoproteins were detected by autoradiography of the blots
with intensifying screens at 
 
2
 
70
 
8
 
C for 
 
z
 
3 d. The blots were subsequently
developed for immunodetection of paralemmin.
 
Immunofluorescence Microscopy in Cell Culture
 
Cell lines were grown at 37
 
8
 
C in DME supplemented with 10% FCS and
50 
 
m
 
g/ml streptomycin, 50 IU/ml penicillin, 2 mM 
 
l
 
-glutamine, 1 mM
pyruvate, in a water-saturated atmosphere with 8% CO
 
2
 
. For PC12 cells,
serum concentrations were 5% FCS and 10% horse serum. Cell were used
2 d after plating. To induce morphological differentiation of NS20Y cells,
medium with 10% FCS was replaced after 2 d by medium with 0.25%
FCS, and culture continued for another 7 d. Cells were seeded on glass
coverslips coated with rat-tail collagen (Sigma Chemical Co.) in 24-well
plates. The FCS-containing medium was removed by rinsing the cells
twice in Locke buffer, followed by fixation in 4% PFA in PBS at room
temperature. Cells were permeabilized with methanol at 
 
2
 
20
 
8
 
C for 6 min.
Before incubation with primary antibodies (diluted in PBS with 1%
BSA), a preincubation for 10 min with 10% normal goat serum in PBS
was carried out to reduce background. Anti-paralemmin was visualized
with a biotinylated goat antiÐrabbit secondary antibody (Vector Labs,
Inc., Burlingame, CA) followed by streptavidin-FITC. In double-immu-
nofluorescence experiments, GAP-43 (mAb 91E12 from Boehringer
Mannheim Corp.) was visualized with a Texas redÐconjugated goat antiÐ
mouse antibody (Dianova). All incubations were for 1Ð2 h with extensive
washings in between. Coverslips were finally mounted in Mowiol (Calbio-
chem-Novabiochem Corp.) supplemented with 50 mg/ml diazo-bicyclo-
octane (Merck, Darmstadt, Germany) and 25 mg/ml propylgallate to re-
duce bleaching of the fluorescent dye. Specimens were viewed on an
Axiophot I microscope (Carl Zeiss, Inc., Thornwood, NY).
 
Functional Expression Experiments
 
Full-length (amino acids 2Ð383) and COOH-terminally truncated (amino
acids 2Ð368) paralemmin sequences, both including exon 8, were ampli-
fied from mouse brain RNA by RT-PCR. The paralemmin sequences
were fused with the NH
 
2
 
-terminal sequence MEQKLISEEDLGSKL that
includes the myc epitope tag, and the whole construct inserted between
the HindIII and XbaI sites of pcDNA3.1/Zeo
 
1
 
 (Invitrogen Corp., Carls-
bad, CA; myc tag engineering by G. Dodt, Institut fr Physiologishe Che-
mie, University of Bochum, Bochum, Germany). Recombinant plasmid
clones were verified by sequencing of the complete inserts. L929, COS-7,
PC12, and GM5756t (Dodt et al., 1995) cells were transfected by the
DEAEÐdextran method. Cells were incubated with the DEAEÐdextranÐ
DNA complex for 4 h, grown for 
 
#
 
3 d, and then processed for immuno-
fluorescence microscopy as described above. The myc immuno-tag was
visualized with the 9E10 mAb (Evan et al., 1985; gift of G. Dodt), and
F-actin with a TRITC-phalloidin conjugate (Sigma Chemical Co.). In ex-
periments using TRITC-phalloidin, cells were permeabilized with 0.2%
Triton X-100 in PBS for 1 min at room temperature. Control transfections
used the green fluorescent protein (GFP) expression plasmid pEGFP-C1
(CLONTECH Labs.).
 
Immunocytochemistry
 
Rats were perfused transcardially with 2.5% glutaraldehyde, 1.5% forma-
lin, 0.1 M sodium phosphate, pH 7.4, for 30 min at 38
 
8
 
C. Fixation was fol-
lowed by a 10-min perfusion with 0.15 M sucrose, 0.1 M sodium phos-
phate, pH 7.4. The tissue was removed, submerged in the latter solution
and cut into 2-mm slices. For immunocytochemical staining, 50-
 
m
 
m vi-
bratome sections from these slices were incubated in free-floating fashion
for 30 min in PBS with 10% normal goat serum and 0.3% Triton X-100,
followed by incubation for 48 h with primary antibody in the same solu-
tion, all at 4
 
8
 
C. After repeated rinsing with PBS and blocking with 0.1%
BSA in PBS for 60 min, sections were incubated for 24 h with biotinylated
goat antiÐrabbit secondary antibody. After washing and blocking, the sec-
tions were finally incubated for 4 h with the avidin-biotinylated peroxi-
dase complex (ABC; Vector Labs, Inc.). Peroxidase activity was visual- 
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ized with 3,3
 
9
 
-diaminobenzidine followed by an enhancement with 0.1%
osmium tetroxide.
For light microscopy, sections were drawn on subbed slides, quickly de-
hydrated and coverslipped. For electron microscopy, the same solutions
were used with the omission of Triton X-100 and the sections were flat
embedded in araldite after the immunocytochemical procedure. Series of
alternating semithin and ultrathin sections were taken from the embedded
tissues. Every second semithin section was counterstained with 1% tolui-
dine blue. Ultrathin sections were contrasted with uranyl acetate and lead
citrate.
Extensive controls were performed to verify the specificity of immuno-
cytochemical staining. The same characteristic ultrastructural localization
of paralemmin-immunoreactive material in brain was seen if perfusion
was carried out with 4% PFA, 0.05% glutaraldehyde, 0.2% picric acid in
0.1 M sodium phosphate, pH 7.4, at room temperature, or if sections were
incubated during the staining procedure in the presence of 1% Triton
X-100. Under both conditions, however, structural conservation was
poorer so that the procedure described above was preferred. The same
staining patterns were obtained with two different affinity-purified rabbit
sera and also with the corresponding whole sera. No staining was obtained
when sections were incubated with preimmune sera or when immune sera
were pre-incubated with recombinant paralemmin. In contrast, pre-incu-
bation of paralemmin antibodies with the recombinant new protein, HSB,
that is partially homologous to paralemmin and mentioned in the first Re-
sults chapter, did not abolish immunodetection of paralemmin, neither on
Western blots (see Fig. 5 
 
B
 
) nor in immunocytochemistry of tissue sec-
tions. This demonstrated that cross-reactivity with this related antigen
does not contribute to the anti-paralemmin staining described here.
 
Results
 
cDNA Cloning and Predicted Primary Structure of 
Paralemmin from Chicken, Human, and Mouse
 
Chicken brain cDNA expression libraries were immuno-
screened with an antiserum raised against the detergent
phase of synaptic plasma membranes subjected to Triton
X-114 phase partitioning. The detergent phase contains
the hydrophobic proteins of this membrane preparation,
in particular intrinsic membrane proteins. One of the
cDNA clones whose expression product reacted immu-
nopositive with this serum was designated ch10.12.1, and it
was selected for further characterization because North-
ern blot hybridization indicated that the corresponding
mRNA is most abundantly expressed in brain (see below).
By several rounds of hybridization rescreening, cDNAs
were isolated that yield the complete coding sequences of
chicken, human, and mouse paralemmin (Figs. 1 and 2).
The cDNAs predict highly charged proteins with an ex-
cess of acidic residues, particularly glutamate (pI values,
4.7Ð4.9), but few cysteines and aromatic amino acids.
There is only one conserved residue each of tyrosine, phe-
nylalanine, and tryptophan in the constitutively expressed
sequences, and two additional conserved tyrosines occur
in the differentially spliced region (see below). Amino acid
sequence identity is 54% between chicken and human,
52% between chicken and mouse, and 80% between hu-
man and mouse. Sequence alignment reveals several re-
gions of very high conservation even between mammals
and birds that are separated, apparently, by poorly con-
served linker sequences (Fig. 2 
 
A
 
). The proteins from the
three species are of very similar size (383Ð387 amino acids)
in spite of a considerable divergence of sequences and also
lengths in individual linker regions.
Most of the paralemmin sequence is predicted to have
high 
 
a
 
 helix potential. The highly conserved NH
 
2
 
-terminal
105 amino acids display a striking periodicity of acidic, ba-
sic, hydrophobic, and glutamine residues, with two poten-
tial leucine zippers, and are predicted to have a high
coiled-coil potential with scores between 1.3 and 2.15 (Fig.
2 
 
B
 
). Database searches confirmed a loose sequence simi-
larity of this region with the coiled-coil regions of various
myosin heavy chains, tropomyosin, and the intermediate
Figure 1. cDNA and deduced amino acid sequences of chicken
and mouse paralemmin. Short reading frames in the 59 untrans-
lated regions and the differentially spliced sequences correspond-
ing to human exon 8 are underlined and printed in bold. The dif-
ferentially spliced chicken exon 7 sequence is underlined and
italicized. The human cDNA sequence has been incorporated
into the gene sequence published elsewhere (Burwinkel et al.,
1998). These sequence data are available from GenBank/EMBL/
DDBJ under accession Nos. Y14769ÐY14771. 
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filamentÐassociated proteins trichohyalin and involucrin.
More pronounced sequence similarity with this and addi-
tional, but not all regions of the paralemmin sequence
is displayed by another novel protein, HSB, that is cur-
rently under study in our laboratory. No other related se-
quences, e.g., from yeast, were found in the database. A
partial sequence (human paralemmin amino acids 203Ð214;
IKVYEDETKVVH) is reminiscent of a sequence stretch
(MKVQQELDETKIVLH) in a lipid-anchored SNARE
protein, Ykt6p, that is involved in ERÐGolgi transport
(McNew et al., 1997). The COOH terminus of paralem-
min carries a characteristic CaaX prenylation consensus
sequence (Fig. 2 
 
C
 
) that will be addressed in more detail
below.
In all three species, the coding sequences are pre-
ceded by GC-rich 5
 
9 
 
untranslated regions. The chicken
and mouse 5
 
9
 
 untranslated sequences contain short read-
ing frames (7 and 17 triplets, respectively; Fig. 1). In the
mouse, this short reading frame is in register with the cod-
ing sequence and thus closes the 5
 
9
 
 end of the long reading
frame. Short reading frames in 5
 
9
 
 untranslated mRNA se-
quences have been implicated in the control of translation
efficiency.
 
Paralemmin mRNA Expression: Tissue Specificity, 
Differential Splicing, and Developmental Regulation
 
Northern blot analysis of chicken, human and mouse
RNAs (Fig. 3) demonstrates an mRNA of 
 
z
 
3,200 nt in all
three species. With chicken RNAs, the hybridization sig-
nal is prominent in forebrain and cerebellum, less intense
in adrenal gland and heart, and weak or undetectable in
the other tissues analyzed. On the human Northern blots,
the paralemmin mRNA is detectable in all tissues ana-
lyzed, again with the highest expression in brain (besides
testis) and intermediate abundance in heart and adrenal
gland. Kidney is the only tissue analyzed in which a second
mRNA band of 
 
z
 
2,500 nt can be seen.
Figure 2. (A) Alignment of the predicted amino
acid sequences of chicken, human, and mouse
paralemmin. The sequence subject to differen-
tial splicing of exon 8 is underlined. Candidate
phosphorylation sites conserved in all three spe-
cies that fit consensus sequences for protein ki-
nase substrates are marked by the following
symbols:  1, casein kinase I; *, casein kinase II;
r, protein kinase A and CaM kinase II; s, pro-
tein kinase C; n, proline-directed kinases; U, ty-
rosine kinases. (References for consensus se-
quences: Kennelly and Krebs, 1991; Songyang et
al., 1995, 1996.) (B) Coiled-coil potential of
chicken, human, and mouse paralemmin deter-
mined with the DNASTAR Protean software
(Macintosh v. 3.04). (C) Alignment of the
COOH-terminal amino acid sequences of
paralemmin, xlgv7, and three Ras isoforms illus-
trating sequence motifs involved in membrane
anchoring. Cysteine residues are in bold print
and basic residues are underlined. Sequences
are taken from Kloc et al. (1991) and references
therein.
Figure 3. Northern blot anal-
ysis of paralemmin mRNA
expression. Blots carry 10 mg
poly(A)1 RNA from chicken
tissues, 2 mg poly(A)1 RNA
from human tissues, 20 mg to-
tal RNA from mouse brain,
and 50 mg total RNA from
cell lines, respectively. Tis-
sues of origin are forebrain
(FB), cerebellum (C), skele-
tal muscle (M), liver (Li),
whole adrenal gland (A), tes-
tis (Te), spleen (Sp), heart
(H), lung (Lu), pancreas
(Pa), whole brain (B), pla-
centa (Pl), kidney (K), adre-
nal medulla (AM), thyroid
gland (Tr), adrenal cortex
(AC), thymus (Tm), small intestine (I), and stomach (St). RNA
from developing mouse brain was isolated on the days of postna-
tal age indicated. Cell lines are: (L) L929 mouse fibroblast cells;
(N 0.5) NS20Y mouse neuroblastoma cells grown for 7 d at low
serum (0.5%); (N 10) NS20Y cells grown for 7 d at high serum
(10%); (N Ca) NS20Y cells treated with calcium ionophore
A23187 for 24 h; (N 2) NS20Y cells grown without A23187 for
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The developmental course of paralemmin mRNA ex-
pression in postnatal mouse brain is shown at the bottom
of Fig. 3. mRNA abundance is highest in neonatal brain
and declines to z50% in adult mice, with the main de-
crease occurring between days 10 and 25.
Paralemmin mRNA is readily detectable in the mouse
neuroblastoma cell lines NS20Y (Fig. 3, bottom, lanes N),
N1E115, NH15CH2, and 108CC15 (not shown) and also in
the mouse fibroblast cell line L929 (Fig. 3, lane L). Mor-
phological differentiation of NS20Y cells by serum with-
drawal does not notably affect the mRNA abundance (Fig.
3, lanes N 0.5 vs. N 10). To test whether protein kinaseÐ
mediated signaling pathways affect paralemmin mRNA
expression, as observed for GAP-43 mRNA (Karns et al.,
1987), neuroblastoma cells were treated with the cAMP-
inducing agents forskolin and IBMX, the calcium ionophor
A23187, and the phorbol ester 12-O-tetradecanoylphorbol-
13-acetate (TPA), and analyzed by Northern blot hybrid-
ization. No significant effects on paralemmin mRNA
abundance were seen (see Fig. 3, lanes N Ca vs. N 2 for the
Ca21 ionophore experiment, other data not shown; experi-
mental details are given in Materials and Methods).
Among the multiple brain cDNA clones analyzed by us,
one mouse and one human clone contained a sequence in-
sert (underlined in Figs. 1 and 2). We suspected differen-
tial mRNA splicing and investigated this by RT-PCR of
different chicken, human, and mouse tissues (Fig. 4).
Based on the human paralemmin gene structure (Bur-
winkel et al., 1998), PCR primers were placed in exons 4
and 9. Agarose gel electrophoresis of RT-PCR products
yielded a characteristic band pattern. Sequencing showed
that the main bands differ by the presence or absence
of exon 8. The bottom-most band only obtained from
chicken brain lacks both exons 7 and 8; additional bands
(Fig. 4, asterisks) are heteroduplexes. The relative expres-
sion of mRNAs with and without exon 8 differs between
tissues, and this tissue specificity is largely conserved be-
tween chicken, mouse, and man. The longer mRNA pre-
dominates in most tissues (most prominently and consis-
tently in skeletal muscle, heart, and lung) whereas the
shorter mRNA prevails in brain and kidney.
The possibility of differential splicing of exon 4 was
probed by RT-PCR of RNA from human brain, kidney,
muscle, heart, liver, fibroblasts, and whole blood, with
primers in exons 3 and 5, but only one amplification prod-
uct of expected size and sequence was obtained from all
tissues (not shown).
Differential splicing of exon 8 in brain is developmen-
tally regulated. The panel at the bottom of Fig. 4 shows
that in newborn mouse brain, the mRNA including exon 8
is hardly detectable. It is induced as the mice grow up,
most pronouncedly between postnatal days 10 and 20.
Paralemmin Analyzed by Immunoblotting:
Anomalous Electrophoretic Migration,
Electrophoretic Heterogeneity, and Tissue Distribution
Fig. 5 A shows a Western blot of brain proteins from rat,
Figure 4. Differential splicing of paralemmin mRNA analyzed by
RT-PCR. The differentially spliced region of chicken, human,
and mouse paralemmin mRNA was amplified by RT-PCR, and
amplification products resolved by agarose gel electrophoresis
and stained with ethidium bromide. The first and third bands
from the top represent RNAs with and without exon 8, and the
second band from the top (asterisk) is a heteroduplex of both.
Chicken forebrain and cerebellum additionally yield a product
lacking both exons 7 and 8, and its heteroduplex (asterisk) with
the Òminus exon 8Ó PCR product. Tissues are designated as in
Fig. 3, additional tissues are ovary (O) and uterus (U).
Figure 5. Electrophoretic heterogeneity and tissue distribution of
paralemmin in Western blot analysis. (A) Brain homogenates
from rat, mouse (ms), chicken (ch), cow (bo), and rabbit (rb) (30
mg protein per lane). (B) Homogenates from mouse tissues (des-
ignations as in Fig. 3; 40 mg protein per lane except A [160 mg]
and M [60 mg]). (C) Brain homogenates from adult (ad.) and neo-
natal (neo.) mouse (10 mg protein). (D) Lysates from NS20Y (20
mg), PC12, and L929 cell lines (both, 60 mg) compared with
mouse forebrain homogenate (FB, 10 mg).Kutzleb et al. Paralemmin, a New Morphoregulatory Plasma Membrane Protein 801
mouse, chicken, cow, and rabbit developed with an antise-
rum raised against recombinant mouse paralemmin. The
blot displays several remarkable features. (a) Multiple
bands are seen in all five species, spread out over consider-
able ranges of apparent molecular size. Moreover, the
electrophoretic mobilities of these arrays of bands differ
considerably between rodents, chicken, cow, and rabbit.
(b) Band patterns from all species consist of a lower and
an upper group, each of which is a series of closely and
evenly spaced individual bands. This is most clearly visible
in the rodents where the band spacing is widest. (c) The
lower main bands of mouse and chicken paralemmin have
apparent molecular sizes of 60 and 65 kD, respectively, as
opposed to a predicted molecular weight of 37.2 kD for
paralemmin, without exon 8, in either species. Thus, elec-
trophoretic mobilities are both slower than expected from
the primary structures, and differ markedly between
paralemmins with the same predicted molecular weights
but from different species. (d) The same band patterns are
observed (not shown) when a Western blot is stained with
antiserum raised against a synthetic peptide spanning
amino acids 13Ð27 of mouse paralemmin, indicating that
all molecules represented by the electrophoretically dis-
tinct bands share this NH2-terminal part (encoded by ex-
ons 2 and 3) of the paralemmin sequence.
Initially, glycosylation was considered as a possible rea-
son for the unexpectedly slow electrophoretic mobility,
the band heterogeneity, and the species differences. How-
ever, treatment of chicken synaptic plasma membranes
with neuraminidase, N-glycosidase F and O-glycosidase
followed by immunoblotting yielded no effects on the
electrophoretic mobility of paralemmin, unlike fetuin as a
positive control (data not shown). It appears therefore
that the slow electrophoretic mobility is not a reflection of
true molecular size but attributable, e.g., to detergent-
resistant conformation motifs or to the acidic character of
paralemmin, in agreement with similarly retarded electro-
phoretic mobility of other acidic proteins like amphi-
physin, GAP-43, MARCKS, and chromogranins. The re-
markable species differences suggest that electrophoretic
mobility is very sensitive to small variations in amino acid
sequence. Mouse and chicken paralemmins have markedly
different mobilities in spite of essentially identical pre-
dicted molecular weights and isoelectric points, and bo-
vine paralemmin migrates slower yet although it is proba-
bly more similar to mouse than to chicken paralemmin in
primary structure.
An immunoblot analysis of homogenates from different
mouse tissues is shown in Fig. 5 B. Expression of paralem-
min protein is distinctly highest in brain, intermediate in
adrenal gland and kidney, and much lower or undetectable
in the other tissues. This tissue distribution of gene prod-
uct abundance agrees well with the Northern blot analysis
of chicken paralemmin mRNA (Fig. 3) but less so with the
human Northern blot. Tissue differences or species differ-
ences in the rates of paralemmin mRNA translation may
account for the discrepancies. All three Northern and
Western blots agree in that brain is the tissue where
paralemmin expression is highest.
Fig. 5 B also shows that the band patterns differ between
tissues. The lower group of bands dominates in kidney and
is expressed in similar abundance as the upper group in
brain and testis, whereas the upper group dominates in all
other tissues. This correlates well with the tissue distribu-
tion of the long and short splicing variants of paralemmin
mRNA (Fig. 4) suggesting that the the lower group of the
Western blot pattern represents the short splicing variant
whereas the long splicing variant underlies the upper
group of bands. This is further corroborated by the obser-
vations that in mouse brain the upper band group is more
intense in adult than in neonatal brain (Fig. 5 C), as is the
longer splicing variant (Fig. 4, bottom), and that in chicken
brain both the upper band group on Western blots (Figs. 5
A and 7 A) and the longer splicing variant (Fig. 4, top) are
very faint. As for the whole protein, the differences be-
tween the upper and lower groups in apparent molecular
size according to electrophoretic mobility (mouse, 20 kD;
chicken, 8 kD) are much larger than the predicted size dif-
ferences of the differential splicing products (5 kD).
In addition to differential splicing, other forms of molec-
ular heterogeneity of paralemmin appear to exist that are
responsible for the fine-structure of the Western blot band
patterns evident particularly in the mouse. In nonneural
tissues and in L929 fibroblast cells, both the upper and the
lower band group each form a doublet, whereas three or
more bands per group are seen in forebrain, cerebellum,
PC12 cells, and NS20Y cells (Fig. 5). Moreover, in the
brain samples, the lowermost bands of each group are very
weak so that the whole band pattern is shifted upwards in
comparison to nonneural tissues (Fig. 5 B) and to cell lines
(Fig. 5 D). Band fine structure also differs between neona-
tal and adult mouse brain (Fig. 5 C). In conclusion, elec-
trophoretic heterogeneity of paralemmin (presumably re-
flecting molecular heterogeneity) is higher in brain and
neuronal cell lines than in nonneural tissues and cells, and
is subject to developmental changes.
Paralemmin Co-distributes with the Plasma Membrane 
in Cell Fractionation and is Protease-sensitive
Fractions of the purification course of chicken synaptic
Figure 6. Distribution of paralemmin among subcellular frac-
tions of the purification course of chicken synaptic plasma mem-
branes, in comparison to GAP-43 and amphiphysin. 25 mg of pro-
tein from each fraction was analyzed by immunoblotting.
Fraction designations are as in Babitch et al. (1976). P290, washed
13,600 rpm pellet of brain homogenate (Òmitochondrial pelletÓ).
Fractions and subfractions of P290 after Ficoll step gradient: Fm,
Òmitochondrial fraction;Ó Scm and Pcm, Òmyelin supernatant and
pellet;Ó Ss and Ps, Òsynaptosomal supernatant and pellet.Ó Frac-
tions and subfractions after hypotonic lysis of Ps synaptosomes:
Pls, Òintrasynaptosomal mitochondria;Ó Phs, large membranes;
Shs, cytosol and small vesicles. Saccharose step gradient fractions
of Phs: 0/0.4, interface between 0 and 0.4 M saccharose, etc.; P, mi-
tochondria-rich pellet. The course of purification of synaptic
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plasma membranes were analyzed by immunoblotting for
paralemmin and the reference proteins, amphiphysin, and
GAP-43 (Fig. 6). Paralemmin is most highly enriched in
the fractions of the final sucrose step gradient (0.4/0.6 and
0.6/0.8) that contain the purified synaptic plasma mem-
branes. It co-distributes with the activity of the plasma
membrane marker protein, Na/K-ATPase (not shown).
The distribution of paralemmin is similar to that of GAP-
43, though GAP-43 is found in some quantity also in the
lighter fractions Shs and 0/0.4 (supernatant of the synapto-
somal lysate and top of the sucrose gradient) in which
paralemmin is very low. In contrast, amphiphysin, which is
primarily synaptic vesicleÐassociated and cytoplasmic, is
abundant in the light fractions. This distribution was found
consistently in two independent synaptic plasma mem-
brane preparations.
In the course of a cell fractionation procedure leading to
the purification of synaptic vesicles from chicken brain,
paralemmin distribution also follows that of GAP-43 and
is distinct from the distribution of the intrinsic synaptic
vesicle protein, SV2 (data not shown). In this analysis, we
also noted that paralemmin is highly sensitive to endoge-
nous proteases, undergoing rapid degradation to multiple
immunopositive bands as soon as protease inhibitors are
omitted in the final steps of the fractionation procedure,
whereas the control proteins (GAP-43, amphiphysin, and
SV2) remained intact. Conserved PEST-like sequences
(rich in proline, glutamate, serine, and threonine residues;
Rechsteiner and Rogers, 1996) in the paralemmin primary
structure (amino acids 92Ð107 and 271Ð282 in chicken)
may contribute to this protease sensitivity.
COOH-terminal Prenylation and Palmitoylation of 
Paralemmin Confer Hydrophobicity, Electrophoretic 
Heterogeneity, and Membrane Attachment
The original paralemmin cDNA, ch10.12.1, was isolated in
an immunoscreening with a serum raised against the de-
tergent phase of synaptic plasma membranes, which con-
tains the hydrophobic proteins, and immunoblot analysis
of the aqueous and detergent phases shows that paralem-
min distributes almost entirely into the latter (Fig. 7 A).
Paralemmin and GAP-43 are in fact the two main antigens
recognized by both screening sera that were raised against
the synaptic plasma membrane detergent phase (Fig. 7 A).
The paralemmin cDNA predicts a highly polar protein
without any hydrophobic stretches that could constitute a
transmembrane domain, but the COOH terminus carries a
combination of three sequence features, highly conserved
between mouse, human, and chicken (Fig. 2 A), that are
known to contribute to the membrane attachment of pro-
teins. A CaaX prenylation consensus motif is immediately
preceded by two additional cysteine residues, and cys-
teines in similar constellations have been shown to be
palmitoylated in several other proteins. Upstream of these
three cysteines (the only conserved cysteine residues in
paralemmin) is a cluster of basic residues; basic clusters
have been demonstrated to contribute to the membrane
association of several proteins in cooperation with lipid
anchors (Hancock et al., 1991; Clarke, 1992; Giannakouros
and Magee, 1992; Magee and Newman, 1992; Cadwallader
et al., 1994). Fig. 2 C aligns the COOH-terminal sequences
Figure 7. Analysis of paralemmin lipidation. (A) Immunoblot of
chicken brain synaptic plasma membranes before (spm) and after
Triton X-114 partitioning into detergent (det.) and aqueous (aq.)
phases, developed with the screening serum (a-D) with which the
original chicken paralemmin cDNA was isolated. The blot dem-
onstrates that paralemmin (diffuse double band near the 66-kD
marker) and GAP-43 (intense band below) are among the main
antigens detected by this serum (15 mg protein per lane). (B) Im-
munoblot of COS-7 cell lysates (100 mg protein each) either ex-
pressing the chicken paralemmin cDNA (1) or transfected with
the corresponding antisense expression plasmid (2), and of
chicken brain synaptic plasma membranes (spm; 30 mg protein).
(C) Prenylation of paralemmin, expressed from the chicken
cDNA in COS-7 cells, demonstrated by metabolic labeling. Ly-
sates (220 mg protein) of COS-7 cells transfected with chicken
paralemmin cDNA in sense (1) or antisense (2) orientation and
grown in the presence of [3H]mevalonolactone were subjected to
immunoprecipitation with an antiserum against recombinant
chicken paralemmin, and the precipitate analyzed by SDS-PAGE
and fluorography for 41 d. (D) Palmitoylation of paralemmin
demonstrated by metabolic labeling with [3H]palmitate. Lysates
(220 mg) of COS-7 cells transfected with chicken paralemmin
cDNA in sense (1) or antisense (2) orientation and grown in the
presence of [3H]palmitate were subjected to immunoprecipita-
tion with an antiserum against recombinant chicken paralemmin,
and the precipitate analyzed by SDS-PAGE and fluorography for
41 d. (E) Release of paralemmin-bound [3H]palmitate by hydrol-
ysis with hydroxylamine. An SDS gel with immunoprecipitates of
[3H]palmitate-labeled paralemmin on two adjacent lanes was pre-
pared as in part D. In this experiment, the lower band of the dou-
blet seen in D was prominent whereas the upper band was very
faint. After fluorography, the gel was re-swollen, cut between the
lanes, and the left lane was incubated in 1 M hydroxylamine, pH
7.5, overnight whereas the right lane was control incubated in
1 M Tris, pH 7.5. Subsequently, both parts of the gel were again
subjected to fluorography. The period of fluorography before
and after hydrolysis was 3 mo each. (F) Inhibition of lipidation af-
fects electrophoretic mobility and hydrophobicity of paralemmin.
COS-7 cells were transfected with chicken paralemmin cDNA in
sense (1) or antisense (2) orientation and grown in the presence
of [35S]methionine and cysteine, plus, where indicated, the inhibi-
tor of prenylation, mevinolin (mev.). Lysates were immunopre-
cipitated, and the precipitates were subjected to Triton X-114
phase partitioning. Aqueous (aq.) and detergent (det.) phases un-
derwent SDS-PAGE followed by fluorography for 9 d. Dots
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of paralemmin with those of Ras isoforms and of a mem-
brane-associated protein from Xenopus laevis, xlgv7. The
COOH terminus of xlgv7 is particularly similar to that of
paralemmin, displaying all three sequence motifs. H-ras
and xlgv7, whose sequences are otherwise unrelated to
paralemmin, have been demonstrated to be both, farnesy-
lated and palmitoylated (Kloc et al., 1991, 1993; and refer-
ences therein).
To see whether paralemmin too is prenylated and pal-
mitoylated, we performed metabolic labeling experiments
in cell culture. The chicken cDNA, encoding the splic-
ing variant without exon 8, was transiently expressed in
COS-7 monkey kidney cells, and an antiserum against the
chicken protein that does not recognize mammalian
paralemmin was used for immunoprecipitation and immu-
noblotting. Fig. 7 B shows an immunoblot of COS-7 cells
transfected with negative control plasmid (2) and chicken
paralemmin cDNA (1), along with chicken synaptic
plasma membranes (spm) as reference. The single cDNA
gives rise to two protein bands, confirming that mecha-
nisms in addition to differential splicing contribute to the
band heterogeneity of paralemmin seen on immunoblots
of tissues and cell lines. The lower cDNA-derived band
comigrates with the lower edge of the main band in
chicken synaptic membranes whereas a counterpart of the
upper band may be part of the diffuse, broad trail charac-
teristic for chicken brain paralemmin. The lower, weak
band of the brain sample has no counterpart in the trans-
fected cells. It probably corresponds to the minor splicing
variant of chicken brain that lacks both exons 7 and 8 (Fig.
4). The comigration of recombinant and native paralem-
min confirms that the cDNA-deduced amino acid se-
quence is full-length, and that the anomalously slow mi-
gration in SDS-PAGE appears to be an intrinsic property
of the polypeptide.
Metabolic labeling for prenylation was performed by
incubating transfected cells with the prenyl precursor,
[3H]mevalonolactone, in the presence of the inhibitor of
endogeneous mevalonate synthesis, mevinolin (Fig. 7 C).
Palmitoylation was detected by labeling with [3H]palmi-
tate (Fig. 7 D). The results show that paralemmin is indeed
both prenylated and palmitoylated. With each label, band
doublets are obtained that probably correspond to the two
bands seen on the Western blot (Fig. 7 B). Additional,
weak bands of lower molecular size (25 and 35 kD) may be
proteolytic degradation products. Prenyl- and palmitoyl-
labeled bands seem to comigrate. Labeling with meva-
lonate does not discriminate between the incorporation of
farnesyl and geranylgeranyl residues as it is a precursor for
both. However, as the COOH-terminal amino acid of
paralemmin is invariably methionine, it is predicted from
previous analysis of prenylation consensus sequences
(Clarke, 1992; Giannakouros and Magee, 1992) that para-
lemmin is farnesylated.
To clarify whether palmitoyl incorporation occurs in-
deed by thioester linkage to the COOH-terminal cysteine
residues rather than by ester bonding to serine or threonine
residues elsewhere in the protein, [3H]palmitate-labeled
paralemmin was incubated either with 1 M hydroxylamine
or 1 M Tris at pH 7.5 (Fig. 7 E). 1 M hydroxylamine at
neutral pH is known to selectively hydrolyze thioester
bonds but neither hydroxyesters nor the thioether bonds
of prenyl residues. The selective disappearance of the ra-
dioactive band in the hydroxylamine-treated lane indi-
cates that palmitate is bound to paralemmin predomi-
nantly or exclusively by thioester linkage.
Fig. 7 F shows that lipidation affects paralemminÕs hy-
drophobicity and electrophoretic mobility. As it is known
that palmitoylation next to prenylation sites depends on
previous prenylation, paralemmin was transiently ex-
pressed from the chicken cDNA in COS-7 cells in the
presence or absence of mevinolin, metabolically labeled
with 35S amino acids, and subjected to immunoprecipita-
tion followed by detergent phase partitioning, SDS-
PAGE, and fluorography. Immunoprecipitation from the
aqueous phases yields a high background of unspecific 35S-
labeled bands. Still, it can be seen that from untreated cells
(1) a doublet with a strong lower and a weak upper band,
similar to the pattern in Fig. 7 D, is immunoprecipitated
that partitions into the detergent phase. In mevinolin-
treated cells (Fig. 7 F, 1, mev.) these bands in the deter-
gent phase are much fainter, whereas two new bands with
faster electrophoretic mobility appear in the aqueous
phase that cannot be seen in the aqueous phase from un-
treated cells. This indicates that prenylation and subse-
quent palmitoylation are responsible for association of
paralemmin with the hydrophobic fraction in Triton X-114
phase partitioning. Moreover, it is demonstrated that the
course of posttranslational processing (which is presum-
ably initiated by prenylation, followed by removal of the
three COOH-terminal amino acids, methylation of the
new COOH terminus [Clarke, 1992; Giannakouros and
Magee, 1992], and the addition of one or two palmitoyl
residues) affects the electrophoretic mobility of paralem-
min and produces at least four electrophoretically distinct
intermediate and end products.
Figure 8. (A) Hydroxylamine hy-
drolysis reduces the hydrophobic-
ity of native paralemmin. Chicken
synaptic plasma membranes (130
mg protein) were incubated for 4 h
with 1 M hydroxylamine, pH 7.5, or
for control, with 1 M Tris, pH 7.5.
After Triton X-114 phase partition-
ing, the aqeous (aq.) and detergent
(det.) phases were subjected to
SDS-PAGE and Western blotting,
and paralemmin and GAP-43 were
simultaneously visualized by devel-
opment with antiserum a-D (com-
pare with Fig. 7 A). (B) Paralemmin in undifferentiated NS20Y
cells is entirely associated with the 120,000 g pellet (p), and mevi-
nolin treatment causes the appearance of paralemmin also in the
120,000 g supernatant (s). NS20Y cells were grown at 10% serum
in the absence (2mev.) of mevinolin and for 12 h in the presence
of 50 mM mevinolin (12 h mev.). Cells were homogenized, sub-
jected to 120,000 g fractionation, SDS-PAGE and blotting, and
then the blot was developed with antibody No. 10 directed
against recombinant mouse paralemmin. Cultivation of the cells in
the presence of mevinolin for 24 h or longer led to pronounced
morphological differentiation, and death and substrate detach-
ment of an increasing number of cells; analysis was therefore ter-
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Native paralemmin of chicken synaptic plasma mem-
branes was also subjected to phase-partitioning, with or
without previous hydroxylamine treatment (Fig. 8 A). The
hydroxylamine incubation is expected to hydrolyze the
palmitoyl thioester bonds but not the prenyl thioether
bonds. GAP-43, which is known to be palmitoylated on
Cys-3 and Cys-4, was visualized as an internal control.
Without hydroxylamine treatment of synaptic plasma
membranes, nearly all of paralemmin and most of GAP-43
distributes into the detergent phase. After hydroxylamine
treatment, approximately half of paralemmin and most of
GAP-43 goes into the aqueous phase. A similar shift from
the detergent to the aqueous phase upon hydroxylamine
treatment is seen with paralemmin from mouse L929 fi-
broblast cells (not shown). These findings indicate that
paralemmin of synaptic plasma membranes and fibroblast
cells in vivo contains thioester-linked palmitate and that
this accounts partially but not completely for the proteinÕs
hydrophobic properties.
To test whether lipidation is responsible for the mem-
brane association of paralemmin, we subjected undifferen-
tiated NS20Y cells to 120,000 g fractionation before and
after mevinolin treatment (Fig. 8 B). Before mevinolin
treatment, paralemmin is found almost entirely in the pel-
let whereas after 12 h growth in the presence of mevinolin,
a notable quantity of paralemmin appears in the cytosolic
fraction. On the blot, it forms a sharp band of high electro-
phoretic mobility. Apparently, pre-existing paralemmin
remains lipidated and membrane attached (prenylation is
believed to be irreversible) whereas paralemmin newly
synthesized in the presence of mevinolin is unlipidated,
electrophoretically more homogeneous, and cytosolic.
The finding that paralemmin of undifferentiated NS20Y
cells distributes almost entirely into the 120,000 g pellet is
notable because immunofluorescence microscopy (see Fig.
11) indicates that paralemmin staining in these cells is to a
large part intracellular. This suggests that also intracellular
paralemmin in undifferentiated NS20Y cells is associated
with a structure that sediments at 120,000 g. As paralem-
min in these cells also partitions nearly completely into the
hydrophobic Triton X-114 phase (not shown), this struc-
ture is probably an intracellular membrane compartment.
Paralemmin Is Phosphorylated
The chicken, human, and mouse paralemmin sequences
contain several conserved consensus sites for potential
phosphorylation by protein kinases A and C, casein ki-
nases I and II, proline-directed protein kinases, and also
for tyrosine phosphorylation (Fig. 2 A). We therefore in-
vestigated whether paralemmin is indeed subject to phos-
phorylation, by metabolic labeling of endogenous paralem-
min of NS20Y neuroblastoma cells with [32P]phosphate
Figure 9. Incorporation of [32P]phosphate into
paralemmin by metabolic labeling. NS20Y cells
were grown in the presence of [32P]phosphate for
4 h, lysed, and then subjected to immunoprecipita-
tion with rabbit antiÐmouse paralemmin serum
No. 10, SDS-PAGE, and then blotting onto nitro-
cellulose. The blot was first exposed to X-ray film
for autoradiography (32P), and subsequently im-
munostained (i) with chicken antiÐmouse paralem-
min serum No. HB.
Figure 10. Subcellular distribution
of endogenous paralemmin visual-
ized by immunofluorescence mi-
croscopy in differentiated NS20Y
neuroblastoma cells, L929 fibro-
blast cells, and PC12 pheochro-
mocytoma cells. The PC12 cells at
bottom right represent the subset of
cells displaying the very intense
staining of a perinuclear, reticular
structure; photographic exposure of
this image was shorter than at the
left where the plasmalemmal and
granular intracellular staining ex-
hibited by all PC12 cells is seen.
Bars: (NS20Y and PC12) 15 mm;
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followed by immunoprecipitation and Western blotting.
Nitrocellulose blots were analyzed both by immuno-
staining with anti-paralemmin antibody and by autorad-
iography. Fig. 9 shows that the array of immunopositive
bands is labeled with 32P, with the notable exception of the
lowermost band. This suggests that either the paralemmin
variant represented by this band cannot be phosphory-
lated (e.g., lipidation might be a prerequisite of phos-
phorylation), or that phosphate incorporation leads to an
upward band-shift and thus contributes to the electro-
phoretic heterogeneity of paralemmin.
Immunofluorescence Microscopy of Paralemmin in
Cell Culture
Affinity-purified antisera against recombinant mouse para-
lemmin were used to visualize the subcellular localiza-
tion of paralemmin. Immunofluorescence microscopy of
NS20Y mouse neuroblastoma cells, induced to differen-
tiation by serum withdrawal, shows that immunopositive
material appears to be associated primarily with the
plasma membrane (Fig. 10; see also Fig. 11). The fluo-
rescence signal outlines the entire periphery of cells and
Figure 11. Redistribution of
paralemmin and GAP-43 to-
ward the periphery of NS20Y
cells in the course of mor-
phological differentiation in-
duced by serum withdrawal.
Cells typical for the different
stages are visualized by
double-immunofluorescence.
Bar, 15 mm.The Journal of Cell Biology, Volume 143, 1998 806
gives thick processes a tube-like appearance. A more in-
tense signal is often observed in places where cells come
close to each other. When the apical or basal regions of
cells are in the plane of focus, it can be seen that also
fine processes and cell surface blebs are labeled. In ad-
dition, a diffuse perinuclear stain is typically seen. N1E-
115 mouse neuroblastoma cells yield the same picture
(not shown). L929 mouse fibroblastoid cells also display
staining of the plasma membrane and of cell extensions.
Often, structures at the poles of these characteristically
spindle-shaped cells give a particularly strong fluores-
cence signal (Fig. 10). PC12 pheochromocytoma cells
display, in addition to staining of the cell periphery,
pronounced labeling of coarsely granular intracellular
structures (Fig. 10, bottom left). About 30% of the PC12
cells additionally display very intense staining of reticu-
lar structures embracing the nuclei and sometimes ex-
tending into cell processes (Fig. 10, bottom right; shorter
exposure than bottom left).
In exploratory double-immunofluorescence experiments
comparing the subcellular localization of paralemmin in
differentiated NS20Y cells to several marker proteins,
we noted a high degree of colocalization with GAP-43.
Because of the role of this protein in cell process forma-
tion, we compared the localization of paralemmin and
GAP-43 during morphological differentiation of the
NS20Y cells by serum withdrawal (Fig. 11). A shift of
paralemmin from the cytoplasm to the plasma membrane
Figure 12. Characteristic aspects of the
morphology of paralemmin overexpress-
ing cells. (a, a9) 1CaaX paralemmin is tar-
geted to the plasmalemma where it con-
centrates at membrane protuberances,
whereas 2CaaX paralemmin is cyto-
plasmic (PC12 cells, immunolabeling with
anti-myc). (b,  b9) Double-fluorescent la-
beling of a 1CaaX-transfected L929 cell
for recombinant paralemmin (anti-myc)
and F-actin (phalloidin). Paralemmin con-
centrates in membrane prominences like
filopodia and microspike clusters, many of
which are also labeled for F-actin (ar-
rows). The cell has a well-structured stress
fiber skeleton qualitatively indistinguish-
able from neighboring non-overexpressing
cells of similar shape (not shown). (c)
Dendritic L929 cell after 1CaaX paralem-
min transfection with labeling of plasma
membrane protuberances including filo-
podia (arrows). Note the bright labeling of
filopodial tips (anti-myc). (d)  1CaaX
paralemminÐexpressing GM5756t cell fea-
turing many long filopodia. Note the dot-
ted pattern of paralemmin along and at
the tips of filopodia (anti-paralemmin la-
beling). (e) COS-7 cell representing the
broadly expanded early stage under
1CaaX paralemmin expression, featuring
a very flat cell shape and relatively smooth
edges and surface (eÐg, anti-paralemmin
labeling). (f) COS-7 cell representing the
partially collapsed later stage under
1CaaX paralemmin expression, featuring
a small but still flat perikaryal area dis-
playing filopodial and lamellipodial mem-
brane activity, and several long thin exten-
sions carrying multiple varicosities. (g)
COS-7 cell representing the late stage un-
der 1CaaX paralemmin expression, fea-
turing a highly condensed cell body ex-
tending few, cable-like processes with
varicosities but little membrane activity.
Note that all three COS-7 cell types (eÐg)
are of equal magnification. Bar: (aÐd) 2.5
mm; (eÐg) 3.8 mm.Kutzleb et al. Paralemmin, a New Morphoregulatory Plasma Membrane Protein 807
in the course of this process was observed. Before serum
withdrawal (day 0), much of paralemmin appears to be
intracellular, with little highlighting of the cell periph-
ery. Paralemmin-immunofluorescence in the cytoplasm
often has a finely granular or vesicular appearance.
GAP-43, at this stage, is already more peripherally lo-
calized, with the plasma membrane outlined more dis-
tinctly, and labeling of fine and occasional short thick
processes that are paralemmin-negative. Upon serum
withdrawal, the cells form neurite-like long extensions
in the course of 7 d. Concurrently, both paralemmin and
GAP-43 translocate towards the plasma membrane and
towards the ends of processes. However, GAP-43 does
so faster and more markedly, labeling many fine ramifi-
cations of the long processes at days 1 and 3, apparently
concurrent with their formation. In contrast, paralemmin
still is largely cytoplasmic at day 1, often with distinct ve-
sicular or granular appearance, and it also enters the
neurite-like processes at days 1 and 3 but does not label
their terminal ramifications as sharply as GAP-43. At
days 5 and 7 the translocation of both proteins is fin-
ished and they give a very similar appearance in immuno-
fluorescence. They now label the circumference of the cell
body, the fine processes extending directly from the cell
body, and the trunks and main branches of long processes.
GAP-43 has apparently withdrawn from the terminal ram-
ifications of long processes that it so strongly labeled dur-
ing their formation.
Figure 13. Overexpression of lipid-anchored
paralemmin (1CaaX) but not of anchor-
less paralemmin (2CaaX) induces spread-
ing and process formation in L929 fibro-
blasts. Typical fluorescence micrographs
are shown of cells 48 and 72 h after trans-
fection with the respective paralemmin
constructs or with pEGFP-C1 (GFP) as
negative control. Photographic negatives
are shown for better reproduction of fine
detail. GFP is visualized by its intrinsic
fluorescence, and paralemmin with anti-
paralemmin immunofluorescence. Note
the background of weakly immunofluores-
cent cells that are either untransfected or
low expressing transfected cells, illustrat-
ing the relative abundances of endogenous versus overexpressed recombinant paralemmin in this experimental system. The GFP and
2CaaX images display the intrinsic tendency of L929 cells to spread and form processes during 3 d in culture that is grossly exaggerated
by 1CaaX paralemmin overexpression. Bar, 11 mm.
Figure 14. Overexpression of lipid-anchored
paralemmin (1CaaX) but not of anchorless
paralemmin (2CaaX) induces spreading and sub-
sequent collapse of COS-7 cells. Typical fluores-
cence micrographs are shown of cells 24, 48, and
72 h after transfection with the respective paralem-
min constructs. Photographic negatives are shown
for better reproduction of fine detail. Control cells
transfected in parallel with pEGFP-C1 (not
shown) displayed shapes indistinguishable from
the  2CaaX-transfected cells at the respective time
points. Recombinant paralemmin is visualized by
immunofluorescence with the myc tag antibody.
Bar, 15 mm.The Journal of Cell Biology, Volume 143, 1998 808
Overexpression of Paralemmin Induces Cell Expansion 
and Process Formation
The molecular properties and subcellular localization of
paralemmin made us suspect an involvement in plasma
membrane dynamics and/or membraneÐcytoskeleton in-
teraction. Plasmids expressing the long splicing variant of
paralemmin including exon 8, tagged with a myc epitope at
the NH2 terminus and either including or lacking the
COOH-terminal 15 amino acids assumed to be responsi-
ble for lipidation-mediated membrane anchoring, were
transfected into several cell lines for transient expression
under the control of the strong CMV promoter. By
double-immunofluorescence microscopy with paralem-
min and myc antibodies, paralemmin levels in transfected
cells were estimated to be severalfold higher than endoge-
nous paralemmin in neighboring untransfected cells (see
Fig. 13).
Full-length recombinant paralemmin was found to asso-
ciate with the plasma membrane in all investigated cell
lines, and to concentrate particularly at sites of membrane
activity such as microspike clusters, filopodia and process
tips (Fig. 12). The COOH-terminally truncated protein, in
contrast, accumulated in the cytoplasm, excluding the nu-
cleus and intracytoplasmic vacuoles, demonstrating that
the COOH-terminal lipidation motif is essential for an-
choring this protein to the plasma membrane (Fig. 12 a9).
At highest magnification, anchorless paralemmin gives a
punctate staining, suggesting that it associates with partic-
ulate or vesicular structures in the cytoplasm.
Overexpression of membrane-anchored paralemmin in-
duced conspicuous changes of cell shape over a time
course of one to three days. Paralemmin-transfected L929
fibroblasts grow very wide and flat and/or extend long pro-
cesses (Figs. 12 c and 13). Stellate and bizarre, segmented
morphologies develop later on. In contrast, L929 cells
transfected with paralemmin lacking the lipid anchor re-
main similar to the untransfected cells surrounding them
and to control cells transfected with GFP, all three cell
groups typically flattening and producing few short pro-
cesses during 3 d in culture (Fig. 13).
Human GM5756t fibroblasts transfected with full-length
paralemmin are also induced to expand and develop bi-
zarre shapes with jagged processes whereas GM5756t cells
transfected with paralemmin lacking the membrane an-
chor remain more slender, similar to the typical fibroblast
shape of untransfected cells (not shown).
Untransfected and GFP-transfected COS-7 cells are flat,
round, or polygonal cells or have a fibroblastoid shape.
Transfected with full-length paralemmin (Figs. 12, eÐg,
and 14, 1CaaX), they grow very wide and flat within the
first day. Many subsequently appear to collapse or re-orga-
nize into compact perikarya with long and thin, cable-shaped
processes that are sometimes highly branched, so that the
cell population becomes very polymorphic after 2 and 3 d
(Fig. 14). In contrast, COS-7 cells transfected with anchor-
less paralemmin (2CaaX) develop no striking changes of
gross morphology. If at all, they shrink rather than expand
during the same time interval. Ruffles and lamellipodia
are, on the average, more frequent and pronounced on
1CaaX cells than on 2CaaX cells (see Fig. 12 f).
The F-actin cytoskeleton of cells was visualized by fluo-
rescent-labeled phalloidin. Neither full-length nor anchor-
less paralemmin elicited significant effects on gross cyto-
skeletal organization, in L929 or COS-7 cells. Stress fiber
scaffolds and cortical actin layers were indistinguishable
from non-overexpressing neighboring cells of similar
shape. Plasma membrane protuberances staining intensely
for paralemmin in 1CaaX-expressing cells were often also
enriched for F-actin (Fig. 12, b and b9, arrows).
PC12 cells displayed the characteristic subcellular local-
izations of 1CaaX and 2CaaX paralemmin (Fig. 12, a and
a9) but developed no striking morphological changes, un-
der the expression of neither of the two constructs.
Immunocytochemical Localization of Paralemmin in 
Rat Brain
As paralemmin is most highly expressed in brain and was
initially identified as a component of synaptic plasma
membranes, we performed an immunocytochemical analy-
sis of rat brain at light and electron microscopic resolution.
Paralemmin-like immunoreactivity is expressed in many
brain areas. Intense staining is characteristic for neuropil-
rich areas wheras myelin fiberÐrich regions are spared.
The cytoplasm of neuronal cell bodies is only faintly
stained. In the cerebellar cortex, for example (Fig. 15), the
molecular layer exhibits strong and homogeneous staining,
the Purkinje cell somata are only slightly stained and the
granule cell layer exhibits a pattern of immunopositive
patches, whereas the medulla is essentially unstained.
By immunoelectron microscopy, immunoreaction prod-
uct is seen in focal aggregates in the perikarya and proxi-
mal dendrites of Purkinje cells, either in the cytoplasm or
in association with the inner face of the plasma membrane
(Fig. 16 A). In the molecular layer, the cross-sectioned
closely packed bundles of unmyelinated axons localized
between the Purkinje cell dendrites, presumably parallel
fibers, display a mosaic of strongly stained, moderately
stained and unstained fibers (Fig. 16, A and B). In longitu-
dinally sectioned areas the parallel fibers are sometimes
stained at intervals, suggesting a discontinuous distribu-
tion of the antigen along the axis of cell processes (Fig. 16
C). However, longitudinally sectioned fibers that were im-
munonegative for long distances were also observed. In
Fig. 16 C, an immunonegative synapse contacts an immu-
nopositive dendritic spine (arrow), presumably an axonal
terminal of a parallel fiber contacting a dendritic spine of a
Purkinje cell.
The patchy immunopositive structures in the granule
cell layer seen by light microscopy (Fig. 15) have a dark
periphery and a lighter center at high magnification, and
are identified as mossy fiber glomeruli in electron micros-
Figure 15. Immunocytochem
ical  visualization of para-
lemmin in rat cerebellum. m,
molecular layer; p, Purkinje
cell layer; g, granule cell layer;
md, medulla. Bar, 72 mm.Kutzleb et al. Paralemmin, a New Morphoregulatory Plasma Membrane Protein 809
copy. Paralemmin-negative mossy fiber terminals are sur-
rounded by numerous granule cell dendrites exhibiting
plasmalemma-apposed aggregates of reaction product
(Fig. 16 D). Occasionally, patches of immunopositive ma-
terial are also observed on the presynaptic side (not
shown), but this is less common.
Discussion
We initially identified paralemmin as a new constituent
protein of synaptic plasma membranes. Immunoelectron
microscopy indicates that, at synapses, it is primarily asso-
ciated with the postsynaptic plasma membrane. It is not
restricted to synapses, though, but is found apparently
throughout the inner face of the neuronal plasma mem-
brane and also in association with a particulate or vesicu-
lar intracellular compartment. Paralemmin is also ex-
pressed in many other tissues and cell types, but the
distinctly highest levels of the protein are found in the
brain, and within the brain, in neuropil-rich regions.
Figure 16. Immunoelectron micrographs of paralemmin-positive structures in the rat cerebellar cortex. (A) The thick proximal Purkinje
cell dendrite (pd) in the molecular layer contains several patches of immunoreaction product and is surrounded by many smaller, heter-
ogeneously stained cell processes, most of them cross-sectioned parallel fibers (magnification shown in B). (C) Longitudinally sectioned
parallel fibers (ax) exhibit a discontinuous distribution of immunoreaction product. An immunonegative axonal terminal contacts a pos-
itive Purkinje cell spine (arrow). (D) In the granule cell layer, immunonegative mossy fiber terminals (mf) are surrounded by several im-
munopositive granule cell dendrites (gd) showing aggregates of immunoreaction product associated with the plasma membrane. Bar:
(A) 750 nm; (B) 200 nm; (C) 400 nm; (D) 300 nm.The Journal of Cell Biology, Volume 143, 1998 810
Several molecular and immunomorphological features
of paralemmin are reminiscent of the proteins, GAP-43,
CAP-23, MARCKS, and MacMARCKS. Like these,
paralemmin is an acidic, highly hydrophilic phosphopro-
tein attached to the plasma membrane through a lipid an-
chor, and it lines the membrane surface not uniformly but
displays a focal distribution (for paralemmin, evident only
in electron microscopy). A direct comparison of the sub-
cellular localization and dynamics of paralemmin and
GAP-43 in differentiating neuroblastoma cells by double-
imunofluorescence microscopy revealed a high degree of
similarity but also subtle differences (Fig. 11). There is no
explicit sequence similarity among paralemmin, GAP-43,
CAP-23, and MARCKS, and the latter three proteins have
been implicated in a variety of cell biological functions
such as formation of cell processes (Zuber et al., 1989;
Aigner et al., 1995; Caroni et al., 1997; Aarts et al., 1998),
phagocytosis (Allen and Aderem, 1995), exocytosis (Dek-
ker et al., 1989; Gamby et al., 1996a), or in signal transduc-
tion (Strittmatter et al., 1993, 1995; Gamby et al., 1996b).
A very general common denominator of GAP-43, CAP-
23, and MARCKS seems to be an involvement in events of
rapid plasma membrane dynamics (Wiederkehr et al.,
1997).
These similarities prompted us to investigate a possible
role of paralemmin in the control of cell shape by overex-
pressing it in several cell lines. In non-neuronal L929,
COS-7, and GM5756t cells the overexpression of full-
length paralemmin produces conspicuous effects on gross
morphology in the course of 1Ð3 d after transfection. All
three cell types profoundly expand their periphery. In
addition to spreading, L929 cells emit long processes and
often develop grotesque multilobar shapes. GM5756t
cells spread and form many short processes. The initial ef-
fect on COS-7 cells is broad circumferential spreading,
whereas the cell processes evident on many transfected
COS-7 cells later on seem to result mainly from secondary
collapse or re-organization of the lamellar cell periphery
in-between (Fig. 12, eÐg). These observations are remark-
ably similar to the long-term effects of GAP-43 overex-
pression on the gross morphology of non-neuronal cells,
which include cell surface expansion, formation of long
processes, and collapse of the most highly expressing cells
(Verhaagen et al., 1994; Gamby et al., 1996a,b; Wie-
derkehr et al., 1997). The morphogenic effects of both,
paralemmin (this work) and GAP-43 (Widmer and Ca-
roni, 1993; Strittmatter et al., 1994; Aarts et al., 1998), de-
pend on an intact lipidation motif to provide membrane
anchoring.
We did not observe similarly significant effects of
paralemmin overexpression on the overall morphology of
the neuronal cell line, PC12. If anything, there may be an
increase of thin, short processes. Conceivably, PC12 cells
possess stronger mechanisms tethering the ÒexpansiveÓ
activity of paralemmin than do the non-neuronal cells, and
higher paralemmin expression levels or additional neurito-
genic stimuli would be needed to overcome them. Re-
markably, also GAP-43 overexpression was found to be
insufficient to trigger process formation in PC12 cells by it-
self, but it potentiated neurite extension stimulated by
nerve growth factor (Yankner et al., 1990).
Overexpression of anchorless paralemmin might be
anticipated to oppose the action of the endogenous pro-
tein by competing for binding partners. We did not see a
striking phenotype under 2CaaX paralemmin expression
though it appeared in some experiments that the number
of shrunken or pycnic cells was indeed higher than among
GFP control cells. More experiments will be needed to
clarify this.
Most studies of the morphogenic activity of GAP-43
have focused on small-scale, rapid plasma membrane dy-
namics such as filopodial activity and blebbing, that occur
on a time scale of minutes to hours. Though we have not
systematically investigated such events, paralemmin is
likely also to stimulate rapid plasma membrane activity.
Filopodia, clusters of microspikes, and other small cell sur-
face prominences are highlighted by immunofluorescence
of 1CaaX-paralemminÐexpressing cells (see Fig. 12). The
tips of filopodia are particularly brightly labeled (Fig. 12, c
and d), suggesting that paralemmin concentrates at adhe-
sion complexes, and the vicinity of filopodially active cells
is often littered with paralemmin-positive adhesion com-
plex remnants (Fig. 12, f and g); interestingly, very similar
observations have been made with GAP-43 in GAP-43Ð
overexpressing fibroblasts (Aarts et al., 1998). Hovever, as
these very fine processes are labeled much more clearly by
plasmalemma-associated full-length paralemmin than by
cytoplasmic anchorless paralemmin, more systematic stud-
ies using a neutral plasma membrane marker for the visu-
alization of these small structures will be needed to clarify
whether they are indeed more numerous or longer on
1CaaX-paralemminÐtransfected cells. In any case, en-
hanced short-term plasma membrane activity must be sup-
posed to occur as a prerequisite of the observed long-term
effects of paralemmin on cell shape, and may now be in-
vestigated in more detail in direct comparison with GAP-
43, MARCKS, and relatives.
GAP-43 and MARCKS colocalize with F-actin at sites
of membrane activity (Widmer and Caroni, 1993; Wie-
derkehr et al., 1997; Allen and Aderem, 1995), bind actin
directly (Hartwig et al., 1992; Hens et al., 1993), and over-
expression of GAP-43 leads to the dissolution of stress
fibers and the accumulation of monomeric and filamen-
tous actin at GAP-43Ðinduced membrane prominences
(Wiederkehr et al., 1997). We also find that many of the
cell prominences immunopositive for recombinant parale-
mmin stain for F-actin, but given the established role of ac-
tin in cell surface activity this is not surprising and does not
imply a direct interaction of the two proteins. The gross
structure of the microfilament cytoskeleton is not notably
affected, neither by full length nor by anchorless paralem-
min, even at the highest levels of expression. Stress fiber
scaffolds and layers of cortical F-actin were typically indis-
tinguishable from those of neighboring untransfected
L929 or COS-7 cells with similar morphologies. Flat COS-
7 cells 1Ð2 d after transfection with full-length paralemmin
often displayed fewer and thinner stress fibers. This proba-
bly reflects the circumstance that these cells are rapidly ex-
panding and likewise need not imply a direct mechanistic
link between paralemmin and actin.
The observed morphogenic effects of paralemmin, to-
gether with the molecular and immunomorphological sim-
ilarities, suggest that it might indeed be grouped with
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tial homologue of MARCKS) to constitute a broadly de-
fined family of lipid-anchored, acidic phosphoproteins in-
volved in the control of plasma membrane dynamics.
Notably, cDNAs of GAP-43, CAP-23, and MARCKS
were also picked up in our immunoscreen together with
paralemmin (see Introduction), suggesting that they all
copurify with synaptic plasma membranes and are strong
immunogens. Little is known yet about the molecular
mechanisms through which these other proteins work,
though functional links, e.g., between GAP-43, the actin
cytoskeleton, and signaling proteins (PKC, calmodulin,
heterotrimeric [Go, Gi], and small G proteins [Rho; Aarts
et al., 1998]) have been identified.
Membrane expansion requires the insertion of addi-
tional membrane surface and the advance and reinforce-
ment of the supporting cytoskeleton. At present, we there-
fore envision possible mechanistic roles for paralemmin
primarily in membrane flow or in membraneÐcytoskeleton
interaction, although roles such as in signal transmission or
in the clustering of other membrane proteins also remain
possible.
Coiled-coil interactions between v- and t-SNARES have
recently emerged as a crucial mechanism in membrane fu-
sion (Ryan, 1998; Weber et al., 1998), and the NH2-termi-
nal region of paralemmin with high coiled-coil potential
may reflect a function as a t-SNARE that mediates the in-
sertion of intracellular membrane vesicles at sites of
plasma membrane expansion. In this context, the similar-
ity of a short sequence tract between paralemmin and
Ykt6p, a SNARE of the VAMP/synaptobrevin family in-
volved in ERÐGolgi transport in yeast that is also mem-
brane-anchored through a COOH-terminal CaaX motif
(McNew et al., 1997), is intriguing, but it remains to be
seen whether this is meaningful. Paralemmin is also associ-
ated with an intracellular compartment that is sediment-
able at 120,000 g and probably vesicular, and that translo-
cates partially to the plasma membrane during neuronal
differentiation of NS20Y cells (Fig. 11). Intracellular
patches of paralemmin immunoreactivity are also seen in
immunoelectron microscopy of neuronal perikarya and
dendrites (Fig. 16 A). Vesicle-associated intracellular para-
lemmin may simply be en route to its final destination on
the plasmalemma, but it might also serve an active role in
vesicle trafficking. In this context, it may be significant
that vesicular/granular intracellular paralemmin is particu-
larly visible in PC12 neuroendocrine cells (Fig. 10) and ad-
renal chromaffin cells (not shown).
The interaction between the plasma membrane and the
underlying cytomatrix must be loosened at sites of vesicle
approach and docking, whereas cytoskeletal structures
must be assembled and anchored underneath recently in-
serted membrane areas. The focal distribution of paralem-
min along the plasma membrane may reflect a function in
the anchoring of the cortical cytoskeleton. Such anchoring
would be crucial for the formation of stable, long cell pro-
cesses as in paralemmin-transfected L929 cells and, impor-
tantly, in the nervous system. On the other hand, the ap-
parent collapse of flat membrane areas after initial radial
expansion of COS-7 cells would suggest a more dynamic
role, where paralemmin would ÒdriveÓ membrane inser-
tion to the point of overstretch where subsequent cyto-
skeletal stabilization by other mechanisms cannot keep pace.
Roles in loosening membraneÐcytoskeleton interaction
have been proposed for GAP-43, CAP-23, and MARCKS
(Wiederkehr et al., 1997).
Paralemmin, GAP-43, CAP-23, and MARCKS are co-
expressed in neurons and may, in different proportions at
different subcellular sites, cooperate in controlling plasma
membrane plasticity versus stability. Whereas GAP-43 is
specific for neurons and glia, the other proteins are ex-
pressed in many cell types but at particularly high abun-
dance in neurons. GAP-43 is concentrated in growth
cones, axons, and synaptic terminals (Gorgels et al., 1989;
van Lookeren Campagne et al., 1990), whereas MARCKS
is also found in dendrites and glial processes (Ouimet et al.,
1990). Postsynaptic spines, a prominent site of paralemmin
localization, require strong and regulated membraneÐ
cytoskeleton interactions both for the maintenance and
the active remodeling of their plasma membrane architec-
ture, e.g., in the interplay with the presynaptic membrane
(Hagler and Goda, 1998) or for rapid actin-dependent
shape changes (Fischer et al., 1998).
In the animal organism, the main effects of a lack or
overexpression of GAP-43, CAP-23, or MARCKS are
in nervous system morphogenesis. Overexpression of
GAP-43 or CAP-23 results in enhanced axonal sprouting
(Aigner et al., 1995; Holtmaat et al., 1995; Caroni et al.,
1997), whereas in GAP-43 knockout mice axons are still
capable of outgrowth but display pathfinding defects
(Strittmatter et al., 1995). Ablation of the MARCKS gene
causes extensive abnormalities in brain development
(Stumpo et al., 1995). The consequences of paralemmin
elimination or overexpression in animals remain to be de-
termined. To search for paralemmin mutations, the chro-
mosomal localization of the paralemmin gene, PALM, has
been determined in mouse (chromosome 10) and man
(19p13.3) (Burwinkel et al., 1998). A protein involved in
cell process formation may cause a neurological pheno-
type but also, e.g., pigmentation defects (compare with the
myosin V mutations: Mercer et al., 1991; Pastural et al.,
1997). The grizzled, mocha, jittery, and hesitant mouse mu-
tations map to the immediate vicinity of the Palm gene
and display such phenotypes, and the paralemmin coding
sequences in these mice have been analyzed but found
normal (Burwinkel et al., 1998).
Comparison of the paralemmin sequences from three
animal species divides the protein into several circum-
script conserved sequence regions that probably represent
functional domains, and it will be of obvious interest to an-
alyze these domains and particularly the differentially
spliced sequence for their contributions to morphogenic
activity and to search for interacting proteins. Immuno-
blotting reveals considerable molecular heterogeneity of
paralemmin, most strikingly in the brain where it is also
subject to developmental regulation. Beside differential
mRNA splicing, different degrees of phosphorylation and
lipidation may contribute to this heterogeneity. There may
be yet additional forms of molecular diversity of paralem-
min, because by combined treatment with alkaline phos-
phatase and hydroxylamine we could only partially reduce
but not abolish band heterogeneity (data not shown). Dif-
ferential splicing, on the other hand, seems to be limited to
exon 8 as RT-PCR experiments between exons 3 and 9
failed to detect other splice products in multiple tissues,The Journal of Cell Biology, Volume 143, 1998 812
and immunoblotting with an antibody against an NH2-ter-
minal peptide encoded by exons 2 and 3 labeled the same
set of bands as an antibody against a sequence reaching
from exons 2 to 9 (see Results). Cells, and particularly
neurons, seem to use multiple molecular variants of
paralemmin to fine-adjust the properties through which
this protein contributes, apparently, to the control of cell
shape.
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